Fiber Global Raises $20 Million Series A to Scale Circular Building Materials Platform
17.6.2025 15:00:00 CEST | Business Wire | Press Release
Fiber Global, a pioneer in sustainable building materials, today announced it has raised $20 million in Series A funding. The round was led by DBL Partners, with Founder and Managing Partner Ira Ehrenpreis joining the Board of Directors. The capital will support Fiber Global’s mission to transform abundant global waste streams into scalable, sustainable building materials, starting with expansion of its U.S. manufacturing footprint.
Fiber Global’s proprietary technology platform converts abundant global waste streams into durable, high-performing building materials capable of outperforming existing solutions with a dramatically lower carbon footprint. Manufactured in the United States, Fiber Global’s products are also formaldehyde free, have zero harmful volatile organic compounds (VOCs), and are UL GREENGUARD GOLD certified. With construction materials responsible for over 10% of global greenhouse gas emissions, Fiber Global aims to lead the transition toward a climate-positive, affordable, and resilient building materials industry through a circular manufacturing approach that also strengthens local economies.
“From day one, our relationship with DBL Partners and Ira Ehrenpreis has been invaluable,”said KC McCreery, Founder and CEO of Fiber Global. “Their team brings more than just investment; they actively engage and support our growth on a daily basis with intentionality. DBL Partners and Ira Ehrenpreis are truly part of the Fiber Global team, sharing our mission and vision of reclaiming tomorrow. This investment round provides us with the ability to continue rapidly scaling our United States manufacturing footprint and production capacity."
Over the past two and a half years, Fiber Global has focused intensely on the execution and scalability of reclaiming global waste streams to build more affordable, better performing, and truly sustainable products. The company is already partnering with leading materials companies to deploy its products across multiple building materials applications, offering a low-carbon alternative without compromising on performance or cost. DBL Partners has a long-standing track record of supporting transformative companies that rethink industry norms and apply deep innovation across both product and processes to redefine what is possible at scale.
“Fiber Global exemplifies the mission-driven, execution-oriented companies DBL seeks to back,” said Ira Ehrenpreis. “KC and his team are building a platform with the potential to revolutionize the building materials sector, combining sustainability, performance, and affordability at scale. Fiber Global is building a better and more economically compelling product that also has a superior environmental footprint, demonstrating how double bottom line is not about tradeoff or compromise but about winning with the best value proposition.”
With increasing global focus on the need to decarbonize the built environment and diversify the supply chains of key building materials, Fiber Global is positioned to meet a surge in demand from partners seeking high-performance, cost-effective, and environmentally cleaner alternatives. The Series A round validates the company’s commercial traction and technology and sets the stage for broader expansion in the years ahead.
About Fiber Global
Fiber Global is a climate technology company redefining building materials through circular innovation. With a mission to reclaim abundant global waste streams to create sustainable, high performing building materials, Fiber Global is driving the shift toward a more resourceful and resilient future. Founded in 2023, the company is headquartered in Brownsburg, IN. Learn more at www.fiberglobal.com.
About DBL Partners
DBL Partners is a pioneering impact investor and among the largest in the venture asset class. The firm invests in companies that can deliver both top-tier venture capital returns and enable social, environmental, and economic benefits. DBL Partners manages over $1.5B in assets, and has helped to scale industry-transforming companies across multiple sectors, including electric vehicles, the earth-space nexus, renewable energy, circular economy, and many others. More information can be found at: www.dbl.vc.
This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding Fiber Global’s growth plans, market opportunities, product capabilities, and expected impacts. These statements are based on current assumptions and estimates and are subject to risks and uncertainties that could cause actual results to differ materially. Forward-looking statements speak only as of the date of this release, and Fiber Global undertakes no obligation to update them in light of new information or future events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250617520583/en/
Contacts
publicrelations@fiberglobal.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom